Overview

Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of intravitreal aflibercept injection in the treatment of PCV
Phase:
Phase 4
Details
Lead Sponsor:
Gregg T. Kokame, MD
Collaborator:
Regeneron Pharmaceuticals
Treatments:
Aflibercept